Bloomberg Businessweek Mount Sinai Announces Rowan Women's Health Center
May 1, 2026
Dr. Fanny Elahi, associate professor of neurology and neuroscience at Icahn School of Medicine, studies neurodegenerative disease and women’s brain health. She discusses Mount Sinai’s new Rowan Women's Health Center and its holistic approach. Conversations cover why women face higher Alzheimer’s risk, rigorous testing of anti‑aging therapies, vascular aging around menopause, hormone replacement limits, and practical lifestyle advice.
AI Snips
Chapters
Transcript
Episode notes
New Center Focuses On Women's Aging Trajectories
- Mount Sinai's Rowan Women's Health Center formalizes integrated women's health research and care focused on aging trajectories.
- The center aims to combine clinical care and research to uncover female-specific risk factors for diseases like Alzheimer's.
Higher Alzheimer's Risk Goes Beyond Longevity
- Women have higher Alzheimer's risk that is not fully explained by longer lifespan alone.
- Elahi emphasizes biological differences and new tools to probe pathways of vulnerability unique to female biology.
Test Anti-Aging Therapies With Randomized Trials
- Rigorous randomized clinical trials are necessary to separate anti-aging hype from proven therapies.
- Mount Sinai is launching trials testing combination treatments to slow aging using established trial methodologies.